It not only leads to an imbalance of vasoactive substances (e.g., nitric oxide and endothelin-1) but also results in impaired vasodilation, increased inflammation, and enhanced thrombosis, all of which are key factors in the development and progression of PAD (31, 34, 35). The gene discussed is EDN1; the disease is peripheral arterial disease.